Endometriosis Knowledgebase


A repository for genes associated with endometriosis

Results


PMID 20172870
Gene Name TBPL2
Condition Endometriosis
Association Associated
Population size 66
Population details 66 (35 patients with histologically confirmed endometriosis, 31 patients without endometriosis)
Sex Female
Associated genes TRX, TBP-2
Other associated phenotypes Endometriosis
The roles of thioredoxin and thioredoxin-binding protein-2 in endometriosis.

Hum Reprod. 2010 May;25(5):1251-8. doi: 10.1093/humrep/deq027. Epub 2010 Feb 19.

Seo, Seok Kyo| Yang, Hyo In| Lee, Kyung Eun| Kim, Hye Yeon| Cho, Sihyun| Choi, Young Sik| Lee, Byung Seok

Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University, College of Medicine, 146-92 Dogok-dong, Gangnam-gu, Seoul 135-720, Korea.

BACKGROUND: Oxidative stress is considered to be involved in the establishment and development of endometriosis. Thioredoxin (TRX) is an endogenous redox regulator that protects cells against oxidative stress, and TRX-binding protein-2 (TBP-2) is a negative regulator of TRX in the biological function and expression. The aim of this study was to investigate the roles of TRX and TBP-2 in the pathophysiology of endometriosis. METHODS: A total of 35 patients with histologically confirmed endometriosis and 31 patients without endometriosis participated in this study. Real-time polymerase chain reaction was used to quantify TRX and TBP-2 mRNA levels, and immunohistochemistry (IHC) was used to assess TRX and TBP-2 protein localization in the endometrium. Serum and peritoneal fluid levels of TRX and TBP-2 were measured using a specific commercial ELISA. RESULTS: There were no significant differences in TRX mRNA levels in the endometrium of patients with endometriosis and the control groups. However, TBP-2 mRNA levels in the endometrium were lower, and the TRX to TBP-2 ratio was higher in patients with endometriosis than in the control group. In particular, the TRX to TBP-2 ratio was significantly higher during late secretory and menstrual phase in patients with endometriosis compared with the control group. IHC studies also showed the decreased TBP-2 immunoreactivity in patients with endometriosis compared with the control group. There was no correlation between TRX and TBP-2 mRNA levels in patients with endometriosis, whereas TRX mRNA levels were positively correlated with TBP-2 mRNA levels in the control group. There were no significant differences between the two groups in TRX and TBP-2 levels in serum or peritoneal fluid. CONCLUSIONS: Aberrant expression of TRX and TBP-2 in the endometrium may be associated with the establishment of endometriosis.

Mesh Terms: Adult| Ascitic Fluid/metabolism| Base Sequence| Carrier Proteins/blood/*genetics/*metabolism| Case-Control Studies| DNA Primers/genetics| Endometriosis/etiology/*genetics/*metabolism| Endometrium/metabolism| Female| Humans| Immunohistochemistry|